With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

The Trump administration is weighing measures that would make it more expensive for pharmaceutical companies to conduct ...

It’s been years since the Cannes Lions International Festival of Creativity awarded its top prize to a traditional ...

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. | Following a ...

Founder and Global CEO of Doceree, returns with Season 2 of “The Next Marketing with HJ”—a one-of-a-kind, knowledge-packed ...

The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...

Four U.S. senators have reintroduced a bipartisan bill focused on strengthening the pharmaceutical supply chain by ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Secretary Robert F. | Following HHS secretary Robert F. Kennedy Jr.’s decision last week to purge the CDC’s Advisory ...

With the FDA's approval of hereditary angioedema preventative treatment Andembry, CSL is ready to take on Takeda’s ...

Two Democratic lawmakers have renewed accusations that large pharma companies have evaded paying U.S. taxes through a ...